Schedule 13D ownership disclosure
TriSalus Life Sciences Inc
Common Stock, $0.0001 par value · CUSIP: 89680M101
Event date: 2025-07-31
Reporting persons may disclose overlapping interests. Their amounts are shown individually and are not added into a filing total.
- Filing-level shares
- Unavailable
- Percent of class
- Unavailable
- Mats WahlstromReported CIK 0001459154
Shares: 2,987,881.00 · Class: 6.0%
- Kerry R. HicksReported CIK 0001110473
Shares: 2,349,795.00 · Class: 4.7%
- HW Investment Partners, LLC
Shares: 1,370,028.00 · Class: 2.8%
- HW Investment Partners, LLC
Shares: 1,370,028.00 · Class: 2.8%
Amounts are as disclosed in this filing. Schedule type alone does not establish investment intent.
Source: SEC EDGAR filingFiling metadata
- Accession number
- 0001826667-25-000106
- Form type
- SCHEDULE 13D/A
- Filer
- TriSalus Life Sciences, Inc.
- CIK
- CIK 1826667
- Filed
- Aug 01, 2025
- Reporting period
- Jul 31, 2025
- Description
- Schedule 13D beneficial ownership